New insights into antigen specific immunotherapy for chronic myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
New insights into antigen specific immunotherapy for chronic myeloid leukemia ; volume:12 ; number:1 ; day:15 ; month:12 ; year:2012 ; pages:1-8 ; date:12.2012
Cancer cell international ; 12, Heft 1 (15.12.2012), 1-8, 12.2012
- Urheber
-
Li, Yangqiu
- Beteiligte Personen und Organisationen
-
Lin, Chen
Schmidt, Christian A.
SpringerLink (Online service)
- DOI
-
10.1186/1475-2867-12-52
- URN
-
urn:nbn:de:1111-2016073018923
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Yangqiu
- Lin, Chen
- Schmidt, Christian A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recent developments in immunotherapy of acute myeloid leukemia
MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Chimeric antigen receptor T cells for acute myeloid leukemia
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Chimeric antigen receptor T cells for acute myeloid leukemia
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Chimeric antigen receptor T cells for acute myeloid leukemia
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
Chimeric antigen receptor T cell therapies for acute myeloid leukemia